Quality of life in pre- and postmenopausal patients with early breast cancer: a comprehensive analysis from the prospective MaLife project.
Norbert MarschnerTanja TrarbachJacqueline RauhDirk MeyerSigrun Müller-HagenJohanna HardeStephanie DilleLisa KruggelMartina Jänickenull nullPublished in: Breast cancer research and treatment (2019)
Despite improvements in global QoL, breast cancer survivors report worsened ailments 3 years after start of therapy. Follow-up care should distinguish between premenopausal patients needing special attention for emotional/menopausal issues, and postmenopausal patients needing particular care regarding physical concerns.
Keyphrases
- end stage renal disease
- ejection fraction
- healthcare
- chronic kidney disease
- newly diagnosed
- palliative care
- quality improvement
- prognostic factors
- stem cells
- chronic pain
- working memory
- bone marrow
- patient reported outcomes
- mesenchymal stem cells
- health insurance
- affordable care act
- cell therapy
- breast cancer risk
- replacement therapy